Caplin Point Laboratories Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

21 May 2019 | 09:54 AM

374.15
1.25 (0.34%)

  • Underperforms Index

    -34.95%

    Return (1Y)

    Underperformed Nifty 500 by 41.13%

  • More Volatile

    3.27%

    Standard Deviation (1Y)

    Higher than Nifty 500 by 2.42%

  • Not so consistent

    5/12

    Months

    underperformed Nifty 500

  • AxisDirect View

    No View

52 Week High-Low

613

613.00

296

296.05

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Caplin Point Laboratories Ltd has increased by 3.33% since past 3 Months

  • FII shareholding in Caplin Point Laboratories Ltd has increased by 17.87% since past 1 Year

  • MF shareholding in Caplin Point Laboratories Ltd has decreased by -100% since past 1 Year

Loading...